Evaluation of the relationship between sex, polymorphisms in CYP2C8 and CYP2C9, and pharmacokinetics of angiotensin receptor blockers.

Cabaleiro, Teresa; Román, Manuel; Ochoa, Dolores; Talegón, María; Prieto-Pérez, Rocío; Wojnicz, Aneta; López-Rodríguez, Rosario; Novalbos, Jesús; Abad-Santos, Francisco

Cabaleiro, Teresa; Román, Manuel; Ochoa, Dolores; Talegón, María; Prieto-Pérez, Rocío; Wojnicz, Aneta; López-Rodríguez, Rosario; Novalbos, Jesús; Abad-Santos, Francisco.

Affiliation

Cabaleiro T; Service of Clinical Pharmacology, Hospital Universitario de la Princesa, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria Princesa, Madrid, Spain. teresa.cabaleiro@salud.madrid.org

Drug Metab Dispos ; 41(1): 224-9, 2013 Jan.

Article in En | MEDLINE | ID: mdl-23118328

Subject(s)

Angiotensin Receptor Antagonists/pharmacokinetics; Aryl Hydrocarbon Hydroxylases/genetics; Polymorphism, Genetic; Sex Factors; Alleles; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Female; Half-Life; Humans; Male; Reference Values

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Aryl Hydrocarbon Hydroxylases / Sex Factors / Angiotensin Receptor Antagonists Limits: Female / Humans / Male Language: En Journal: Drug Metab Dispos Journal subject: FARMACOLOGIA Year: 2013 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google